GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » PB Ratio

Marinomed Biotech AG (STU:93Z) PB Ratio : (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-21), Marinomed Biotech AG's share price is €16.05. Marinomed Biotech AG's Book Value per Share for the quarter that ended in Dec. 2023 was €-6.65. Hence, Marinomed Biotech AG's PB Ratio of today is .

The historical rank and industry rank for Marinomed Biotech AG's PB Ratio or its related term are showing as below:

During the past 9 years, Marinomed Biotech AG's highest PB Ratio was 767.44. The lowest was 7.80. And the median was 18.43.

STU:93Z's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.53
* Ranked among companies with meaningful PB Ratio only.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Marinomed Biotech AG was -150.80% per year. The lowest was -150.80% per year. And the median was -150.80% per year.

Back to Basics: PB Ratio


Marinomed Biotech AG PB Ratio Historical Data

The historical data trend for Marinomed Biotech AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG PB Ratio Chart

Marinomed Biotech AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 13.39 31.89 675.97 - -

Marinomed Biotech AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Marinomed Biotech AG's PB Ratio

For the Biotechnology subindustry, Marinomed Biotech AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marinomed Biotech AG's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's PB Ratio falls into.



Marinomed Biotech AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Marinomed Biotech AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=16.05/-6.652
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Marinomed Biotech AG  (STU:93Z) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Marinomed Biotech AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Marinomed Biotech AG (STU:93Z) Business Description

Traded in Other Exchanges
Address
Hovengasse 25, Korneuburg, AUT, 2100
Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (STU:93Z) Headlines

No Headlines